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Case ReportsContinuous renal replacement therapy and mild hypothermia for
acute left heart failure after cardiovascular surgeryYu Du, MM, Haitao Zhang, MM, and Xue Feng, MD, Beijing, ChinaManagement of severe heart failure with high doses of ino-
tropes and vasopressors and increased ventricular volume
will result in a high work load for the failing heart, with
progressive decompensation. Recovery of heart function
as a result of a period of rest for a failing heart has been
well documented. However, few hospitals in China
currently have the resources to provide extracorporeal
membrane oxygenation or left ventricular assist device
services. Management has continued to be a major
challenge for cardiovascular surgical teams. We report a
new strategy of combined continuous renal replacement
therapy (CRRT) and mild hypothermia (MHT) to provide
a period of rest for the severely failing heart to achieve
recovery of cardiac function adequate for survival.CASE REPORT
A 31-year-old man with Marfan syndrome underwent an
emergency Bentall procedure for acute aortic dissection
with aortic insufficiency. The preoperative left ventricular
ejective fraction was 32%, and he was in New York Heart
Association class IV. The cardiopulmonary bypass time
was 75 minutes, and the crossclamp time was 45 minutes.
Postoperative acute left heart failure was diagnosed from
the clinical manifestations, hemodynamic data, and
ultrasound findings. It was initially managed with high
doses of inotropes and vasopressors (eg, dopamine,
epinephrine, norepinephrine) to maintain a mean artery
pressure >70 mm Hg. The cardiac index (CI) was
<2.2 L/min/m2. The pulmonary artery wedge pressure
(PAWP) was>20 mm Hg, and the left ventricular ejection
fraction was <30%. The urine output was <0.5 mL/kg
for 6 hours, and the arterial lactate was >3.0 mmol/L.
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hours after surgery, CRRT was started with a Prisma
automatic continuous renal replacement system (Gambro
Dasco SpA, Medolla, Italy). During CRRT, the extracorpo-
real circulation lines were submerged in ice water to
maintain the core body temperature at 34C. His core
body temperature was 38.8C before CRRT/MHT and
decreased to 34.2C after 3 hours of treatment. The fluid
intake and output were adjusted such that the fluid output
was greater than his intake, and the PAWP was 10 to
12 mm Hg. The PAWP decreased from 23 to 13 mm Hg
after 10 hours of treatment and was maintained at 10 to
12 mm Hg during the entire period of CRRT/MHT. The
dosages of inotropes and vasopressors were gradually
reduced to maintain the mean artery pressure at 60 to
70 mm Hg and CI at >1.0 L/min/m2. An intravenous
heparin infusion was used to maintain the activated whole
blood clotting time at 120 to 140 seconds. Replacement
therapy included maintaining the plasma albumin at
>35 g/L and platelet count at >5.5 3 109/L. During
CRRT/MHT, the doses of inotropes and vasopressors
were substantially decreased (Figure 1). By the fifth day
of CRRT/MHT, his cardiac function had gradually recove-
red. When the CI had increased to 1.8 to 2.2 L/min/m2, with
the PAWP stable at 10 to 12mmHg and the echocardiogram
showed improved contractility of the myocardium with a
left ventricular ejection fraction >45%, the core body
temperature was gradually increased to 37.3C. Also, the
dose of inotropes and the volume load were adjusted to
maintain the mean artery pressure at 80 to 85 mm Hg.
CRRT was gradually discontinued. The total CRRT period
was 136 hours. With the institution of CRRT/MHT, the
CI had decreased from 2.0 to 1.7 L/min/m2. After
CRRT/MHT was discontinued, the CI had increased to
3.4 L/min/m2. During the CRRT/MHT period, he had had
nearly no urine output, and serum creatinine was
controlled at 98 to 130 mmol/L using CRRT. The urine
output had recovered to normal by 48 hours after the
CRRT had been discontinued, and his renal function had
recovered to normal without additional renal replacement
therapy. The patient survived in the intensive care unit
and hospital.DISCUSSION
The primary goal of the CRRT/MHT strategy was to
reduce the work of the heart to facilitate recovery ofdiovascular Surgery c Volume 148, Number 1 e137
FIGURE 1. Dosages of dopamine, epinephrine, and norepinephrine before continuous renal replacement therapy (column a), during CRRT (column b), and
after CRRT discontinuation (column c). Black triangle indicates the amount of norepinephrine was 0.
Case Reportsmyocardial function. Catecholamine use was substantially
decreased and could well have importantly contributed to
the reduction in cardiac oxygen consumption and survival
of the patient. Myocardial recovery and the reduction of
catecholamine drugs could have been facilitated by the pos-
itive inotropic effect of mild hypothermia,1 the increased
systematic vascular resistance contributed by the mild
hypothermia,2 and the correction of acidosis by CRRT.
As the temperature decreases by 1C, the overall meta-
bolic rate will decrease by about 8%. When the temperature
has decreased to 32C, the overall metabolic rate will
decrease by about 50% to 60%, and, accordingly, oxygen
consumption and carbon dioxide production will be
reduced.3 With the decreased metabolic demand, mild hy-
pothermia will result in an important decrease in the work
of the heart. A newmetabolic balance will be reached underTABLE 1. Data from another 11 patients with acute left heart failure afte
Pt.
no. Age (y) Gender Primary illness Procedure
Preop
EF (%
cl
1 39 F AD þ AI þ MR Bentall þ TS þ MVR 47
2 27 M AD þ AI þ MR Bentall þ MVR 71
3 37 F AD ATS 67
4 65 F CHD CABG 65
5 54 F MR MVR 59
6 41 F AD ATS 70
7 40 F AD ATS 54
8 57 M MS þ MR MVR þ TVP 41
9 17 F TOF TOF correction 51
10 25 F MS MVR 52
11 55 M MS þ MR þ AS MVR þ TVP 63
No persistent renal failure occurred that required dialysis.Pt. no., Patient number; EF, ejecti
therapy;MHT, mild hypothermia; ICU, intensive care unit;F, female; AD, aortic dissection;
with stented elephant trunk implantation; MVR, mitral valve replacement; M, male; ATS, a
plantation; CHD, coronary heart disease; CABG, coronary artery bypass grafting; MS, mit
*Two patients died in the ICU of refractory heart failure. yOne patient died of rupture of
normal.
e138 The Journal of Thoracic and Cardiovascular Surmild hypothermia, and organ perfusion can better supply
the metabolic needs in the presence of acute heart failure
and gain time for recovery of cardiac function adequate
for survival.
CRRT reduces the cardiac preload promptly by ultrafil-
tration.4 When this has been accompanied by a reduction
in the use of inotropes and vasopressors, the work of the
heart and overall oxygen consumption will decline,
achieving ‘‘unloading’’ of the heart. CRRT controls the
body temperature rapidly and accurately and has also
been effective in avoiding the chills and pressure sores
seen with surface cooling.
In our clinical practice, an additional 11 patients have
experienced acute left heart failure after cardiac surgery
and were treated with the CRRT/MHT strategy with
good outcomes (Table 1). Similar reports of hypothermiar cardiac surgery who underwent CRRT/MHT strategy
erative
)/NYHA
ass
Interval to
initiation of
CRRT/MHT
postoperatively (h)
Total
CRRT/MHT
duration (h)
Survived
in ICU*
Survived
in hospitaly
/III 8 164 Yes Yes
/II 15 155 Yes Yes
/II 22 105 Yes No
/II 17 170 Yes Yes
/III 25 135 Yes Yes
/II 32 116 Yes Yes
/III 14 111 Yes Yes
/IV 16 183 Yes Yes
/II 20 179 No —
/III 10 163 Yes Yes
/III 22 143 No —
on fraction;NYHA, NewYork Heart Association;CRRT, continuous renal replacement
AI, aortic insufficiency;MR, mitral regurgitation; TS, total arch replacement combined
scending aorta and total arch replacement combined with stented elephant trunk im-
ral stenosis; TVP, tricuspid valveplasty; TOF, tetralogy of Fallot; AS, aortic stenosis.
a residual aortic dissection 20 days after cardiac and renal function had recovered to
gery c July 2014
Case Reportscombined with intra-aortic balloon pump support after
heart surgery have also been published, with good out-
comes.5,6 Randomized clinical studies are needed to
evaluate the efficiency and safety of the CRRT/MHT
strategy in acute left heart failure after cardiovascular
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